VERU INC. Prepaid Expense and Other Assets, Current
VERU INC. (VERU) had Prepaid Expense and Other Assets, Current of $1.44 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-10
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.44M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $2.59M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.41M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $595.25K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.44M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $2.59M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.41M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $595.25K 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $1.18M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.36M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.77M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $805.63K 10-K · filed 2025-12-17 | $1.78M 10-K · filed 2024-12-16 |
| 2024-06-30 | $1.62M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.88M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $2.24M 10-Q · filed 2024-04-01 | |
| 2023-09-30 | $1.10M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $1.37M 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $2.13M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.07M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $1.96M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $2.17M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.66M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.94M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $850.89K 10-K · filed 2022-12-05 | |
| 2021-06-30 | $1.44M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.93M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $3.32M 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $881.27K 10-K · filed 2021-12-02 | $1.49M 10-K · filed 2020-12-10 |
| 2020-06-30 | $2.13M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $3.08M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $2.08M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $1.84M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $1.21M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.22M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.21M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $1.15M 10-K · filed 2019-12-12 | |
| 2018-06-30 | $958.48K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $629.53K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $625.50K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $833.71K 10-K · filed 2018-12-13 | $697.10K 10-K · filed 2018-01-02 |
| 2017-06-30 | $800.81K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $607.96K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $720.94K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $634.59K 10-K · filed 2018-01-02 | |
| 2016-06-30 | $544.26K 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $276.36K 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $316.68K 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $609.32K 10-K · filed 2016-12-12 | |
| 2015-06-30 | $518.48K 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $383.17K 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $452.80K 10-Q · filed 2015-02-03 | |
| 2014-09-30 | $638.24K 10-K · filed 2015-12-02 | |
| 2014-06-30 | $374.29K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $288.93K 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $452.93K 10-Q · filed 2014-02-03 | |
| 2013-09-30 | $514.21K 10-K · filed 2014-12-02 | |
| 2013-06-30 | $558.14K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $638.24K 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $593.38K 10-Q · filed 2013-01-30 | |
| 2012-09-30 | $624.27K 10-K · filed 2013-12-03 | |
| 2012-06-30 | $307.28K 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $322.80K 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $211.79K 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $297.27K 10-K · filed 2012-12-04 | |
| 2011-06-30 | $369.41K 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $284.95K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |